Pure Global: Brazil's New MedTech Shortcut & ANVISA's Hidden Compliance Toll. episode artwork

EPISODE · Mar 28, 2026 · 2 MIN

Pure Global: Brazil's New MedTech Shortcut & ANVISA's Hidden Compliance Toll.

from LATAM MedTech Insights

This week, we dive into a landmark regulatory shift in Brazil. ANVISA has just unveiled a new "Reliance" pathway, promising an incredible 80% reduction in review time for medical devices already approved by MDSAP authorities. This could dramatically accelerate market access for many international firms. However, this new shortcut comes with a critical catch. At the same time, ANVISA has implemented stricter, IMDRF-aligned standards for essential safety and performance requirements. This means the technical documentation bar has been raised significantly, potentially creating new hurdles even for experienced manufacturers. We break down the opportunity and the hidden challenge. We explore the case of a U.S. orthopedic implant company, whose dream of a fast-track approval was met with the harsh reality of a complete technical file overhaul, forcing them to navigate the gap between their existing FDA compliance and Brazil's new, tougher standards. This week, you'll learn: - What are the exact eligibility criteria for ANVISA's new Reliance pathway? - How does the new RDC 848 resolution change your technical documentation checklist forever? - Which common gaps exist between an FDA-approved file and the new IMDRF-based requirements? - Is the Reliance pathway a guaranteed approval, or are there still hidden pitfalls? - What is the first step your company should take right now to adapt to this new landscape? - How can you leverage your existing international approvals most effectively for the Brazilian market? - What are the critical risk management updates required under the new regulations? Navigating the complexities of global markets is our expertise. At Pure Global, we provide end-to-end regulatory consulting for MedTech and IVD companies, using local expertise and advanced data tools to streamline your market access. Whether it's adapting your technical dossier for Brazil's new standards or acting as your local representative, we clear the path for your innovation. Contact us at [email protected] or visit https://pureglobal.com/.

Episode metadata supplied by the publisher feed · Published Mar 28, 2026

Embed this episode

NOW PLAYING

Pure Global: Brazil's New MedTech Shortcut & ANVISA's Hidden Compliance Toll.

0:00 2:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of LATAM MedTech Insights?

This episode is 2 minutes long.

When was this LATAM MedTech Insights episode published?

This episode was published on March 28, 2026.

Can I download this LATAM MedTech Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!